Gene: ZNF316
Official Full Name: zinc finger protein 316provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12309 | ZNF316 Knockout cell line (HeLa) | Human | ZNF316 | 1:3~1:6 | Negative | Online Inquiry |
KO12310 | ZNF316 Knockout cell line (HCT 116) | Human | ZNF316 | 1:2~1:4 | Negative | Online Inquiry |
KO12311 | ZNF316 Knockout cell line (HEK293) | Human | ZNF316 | 1:3~1:6 | Negative | Online Inquiry |
KO12312 | ZNF316 Knockout cell line (A549) | Human | ZNF316 | 1:3~1:4 | Negative | Online Inquiry |
ZNF316 Gene Knockout Cell Lines are specially engineered cell lines in which the ZNF316 gene has been inactivated, allowing for a comprehensive study of its functions in cellular mechanisms. ZNF316, a member of the zinc finger protein family, is implicated in various regulatory processes, including transcriptional control and cellular response to stress. By utilizing these knockout cell lines, researchers can delineate the biological roles of ZNF316, leading to insights into its involvement in gene expression, cellular differentiation, and potential links to disease states.
The primary function of ZNF316 Gene Knockout Cell Lines is to provide a platform for the analysis of ZNF316's role in vivo and in vitro. Through the precise targeting and disruption of the ZNF316 gene, researchers can observe phenotypic changes and alterations in signaling pathways. This gene editing technique allows for the investigation of molecular interactions and functions that are otherwise obscured in wild-type cell lines. Furthermore, ZNF316 knockout models can be pivotal in studying cancer biology, neurodegenerative diseases, and other pathophysiological conditions that might implicate zinc finger proteins.
In research and clinical settings, these knockout cell lines serve as invaluable tools for drug discovery and development, particularly when exploring targeted therapies. Their utility extends to functional genomics, where understanding the specific role of ZNF316 could lead to breakthroughs in the treatment of diseases linked to aberrant gene expression. Moreover, compared to conventional cell lines, ZNF316 knockout variants offer a more accurate representation of physiological conditions, enhancing the translational potential of research findings.
The unique selling points of ZNF316 Gene Knockout Cell Lines lie in their specificity, reliability, and the depth of gene function analysis they facilitate. Compared to alternative models that may not adequately mimic the gene's knockout effects, these engineered lines provide a precise investigative tool that is essential for modern scientific inquiry.
For researchers, clinicians, and pharmaceutical companies seeking to uncover new therapeutic avenues, ZNF316 Gene Knockout Cell Lines provide a strategic advantage. Leveraging our expertise in gene editing technologies and cell line development, we deliver high-quality products that empower scientific advancements and foster innovation in biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.